标题
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-05
DOI
10.1186/s12933-020-01188-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases
- (2020) Shizuya Yamashita et al. Current Atherosclerosis Reports
- FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes
- (2020) Dan Yan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
- (2019) Zhongwei Yin et al. Cardiovascular Diabetology
- Cardiomyopathy in obesity, insulin resistance or diabetes
- (2019) Michinari Nakamura et al. JOURNAL OF PHYSIOLOGY-LONDON
- The Efficacy and Safety of Pemafibrate in Patients with Type 2 Diabetes and Elevated Triglyceride levels: 52-Week Data From The PROVIDE Study
- (2019) Eiichi Araki et al. DIABETES OBESITY & METABOLISM
- Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of MajorAdverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
- (2019) Thomas A. Zelniker et al. CIRCULATION
- Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency
- (2019) Kim L Ho et al. CARDIOVASCULAR RESEARCH
- Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and meta-analysis
- (2019) Satoshi Ida et al. Cardiovascular Diabetology
- Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases
- (2019) Shizuya Yamashita et al. Journal of Atherosclerosis and Thrombosis
- The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
- (2019) Jean-Charles Fruchart et al. Cardiovascular Diabetology
- Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure
- (2019) Golam M. Uddin et al. Cardiovascular Diabetology
- Metformin Promotes Anxiolytic and Antidepressant-Like Responses in Insulin-Resistant Mice by Decreasing Circulating Branched-Chain Amino Acids
- (2019) Juliane Zemdegs et al. JOURNAL OF NEUROSCIENCE
- The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date
- (2019) Christina Antza et al. Drug Design Development and Therapy
- Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
- (2019) Jierong Luo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway
- (2018) Lujin Wu et al. AGING CELL
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
- (2018) Eiichi Araki et al. DIABETES CARE
- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2018) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
- (2018) Hidenori Arai et al. Journal of Atherosclerosis and Thrombosis
- Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia
- (2018) Shizuya Yamashita et al. Journal of Clinical Lipidology
- Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial
- (2018) Shun Ishibashi et al. Journal of Clinical Lipidology
- Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance
- (2018) Ikuro Matsuba et al. Journal of Diabetes Investigation
- Cardiac Branched-Chain Amino Acid Oxidation is Reduced During Insulin Resistance in the Heart
- (2018) Natasha Fillmore et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving ‘SIRT1 and PGC-1α’
- (2018) Maayan Waldman et al. Cardiovascular Diabetology
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Membrane potential determines calcium alternans through modulation of SR Ca 2+ load and L-type Ca 2+ current
- (2017) Giedrius Kanaporis et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice
- (2017) Kenta Takei et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- The diabetic heart utilizes ketone bodies as an energy source
- (2017) Yuji Mizuno et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
- (2017) Kenneth W. Mahaffey et al. CIRCULATION
- Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
- (2016) Shun Ishibashi et al. ATHEROSCLEROSIS
- Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure
- (2016) Kenneth C. Bedi et al. CIRCULATION
- The Failing Heart Relies on Ketone Bodies as a Fuel
- (2016) Gregory Aubert et al. CIRCULATION
- Catabolic Defect of Branched-Chain Amino Acids Promotes Heart FailureCLINICAL PERSPECTIVE
- (2016) Haipeng Sun et al. CIRCULATION
- Branched-chain amino acids as biomarkers in diabetes
- (2016) Pieter Giesbertz et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator–Activated Receptor α
- (2016) Xuqing Chen et al. DIABETES
- Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis
- (2016) Sunder Mudaliar et al. DIABETES CARE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
- (2016) Anders Jorsal et al. EUROPEAN JOURNAL OF HEART FAILURE
- Exendins and exendin analogs for diabetic therapy: a patent review (2012-2015)
- (2016) Eun Ji Park et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Novel ketone diet enhances physical and cognitive performance
- (2016) Andrew J. Murray et al. FASEB JOURNAL
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
- (2016) Kenneth B. Margulies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance
- (2016) Cholsoon Jang et al. NATURE MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets
- (2015) Miranda M. Sung et al. ANTIOXIDANTS & REDOX SIGNALING
- Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and DeathCLINICAL PERSPECTIVE
- (2015) Matthew A. Cavender et al. CIRCULATION
- Activating PPAR Prevents Post-Ischemic Contractile Dysfunction in Hypertrophied Neonatal Hearts
- (2015) V. H. Lam et al. CIRCULATION RESEARCH
- Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure UponPparα Deficiency
- (2015) Michal Pawlak et al. MOLECULAR ENDOCRINOLOGY
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
- (2015) Guanghong Jia et al. Nature Reviews Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
- (2014) Benjamin M. Scirica et al. CIRCULATION
- Myocardial Contractile Dysfunction Is Associated With Impaired Mitochondrial Function and Dynamics in Type 2 Diabetic but Not in Obese Patients
- (2014) David Montaigne et al. CIRCULATION
- Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
- (2014) Ffolliott M. Fisher et al. GASTROENTEROLOGY
- Metabolic Impairment in Heart Failure
- (2014) Wolfram Doehner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Branched-chain amino acids in metabolic signalling and insulin resistance
- (2014) Christopher J. Lynch et al. Nature Reviews Endocrinology
- 1H-NMR-Based Metabolic Analysis of Human Serum Reveals Novel Markers of Myocardial Energy Expenditure in Heart Failure Patients
- (2014) Zhiyong Du et al. PLoS One
- PGC-1α-Mediated Branched-Chain Amino Acid Metabolism in the Skeletal Muscle
- (2014) Yukino Hatazawa et al. PLoS One
- Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation
- (2014) J. Fuentes-Antrás et al. International Journal of Endocrinology
- Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
- (2014) Rebecca C. Schugar et al. Molecular Metabolism
- Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a
- (2013) Craig W. Younce et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR
- (2013) Jordan Gallinetti et al. BIOCHEMICAL JOURNAL
- Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
- (2013) Richard G. Bach et al. CIRCULATION
- Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy
- (2013) T.-I. Lee et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- O-GlcNAc and the cardiovascular system
- (2013) Sujith Dassanayaka et al. PHARMACOLOGY & THERAPEUTICS
- Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure
- (2012) Aalap Chokshi et al. CIRCULATION
- Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
- (2012) K. Huynh et al. DIABETOLOGIA
- PGC-1 Proteins and Heart Failure
- (2012) Christian Riehle et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Effect of fenofibrate treatment for hyperlipidaemia on serum creatinine and cystatin C
- (2012) V. Ncube et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Selective Regulation of Cardiac Organic Cation Transporter Novel Type 2 (OCTN2) in Dilated Cardiomyopathy
- (2011) Markus Grube et al. AMERICAN JOURNAL OF PATHOLOGY
- Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit?
- (2011) Y. Huang et al. CARDIOVASCULAR RESEARCH
- Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study
- (2011) Marcus Lind et al. LANCET
- Potential Role of Nuclear FactorκB in Diabetic Cardiomyopathy
- (2011) O. Lorenzo et al. MEDIATORS OF INFLAMMATION
- New Regimens to Prevent Tuberculosis in Adults with HIV Infection
- (2011) Neil A. Martinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosiglitazone Revisited
- (2010) Steven E. Nissen et al. ARCHIVES OF INTERNAL MEDICINE
- Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation
- (2010) Liyan Zhang et al. CARDIOVASCULAR RESEARCH
- PGC-1 Coactivators in Cardiac Development and Disease
- (2010) Glenn C. Rowe et al. CIRCULATION RESEARCH
- Role of KLF15 in Regulation of Hepatic Gluconeogenesis and Metformin Action
- (2010) M. Takashima et al. DIABETES
- Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice
- (2010) A. Maida et al. DIABETOLOGIA
- Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
- (2010) M. Komajda et al. EUROPEAN HEART JOURNAL
- Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
- (2010) David J. Graham et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impaired Glucose Tolerance and Insulin Resistance in Heart Failure: Underrecognized and Undertreated?
- (2010) Mamas A. Mamas et al. JOURNAL OF CARDIAC FAILURE
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- PPARα: an emerging therapeutic target in diabetic microvascular damage
- (2010) Anne Hiukka et al. Nature Reviews Endocrinology
- Combination Lipid Therapy in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Myocardial Fatty Acid Metabolism in Health and Disease
- (2010) Gary D. Lopaschuk et al. PHYSIOLOGICAL REVIEWS
- Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding
- (2009) Jordan J. Wright et al. CARDIOVASCULAR RESEARCH
- NF-κB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes
- (2009) Nithya Mariappan et al. CARDIOVASCULAR RESEARCH
- Cardiac peroxisome proliferator-activated receptor-α activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss
- (2009) Anne D. Hafstad et al. CARDIOVASCULAR RESEARCH
- Insulin-Stimulated Cardiac Glucose Oxidation Is Increased in High-Fat Diet-Induced Obese Mice Lacking Malonyl CoA Decarboxylase
- (2009) J. R. Ussher et al. DIABETES
- Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes
- (2009) J. Cuthbertson et al. DIABETIC MEDICINE
- Altered Myocardial Substrate Metabolism and Decreased Diastolic Function in Nonischemic Human Diabetic Cardiomyopathy
- (2009) Luuk J. Rijzewijk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myopathy with statin–fibrate combination therapy: clinical considerations
- (2009) Terry A. Jacobson Nature Reviews Endocrinology
- Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat
- (2008) Vijay Sharma et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Diabetes, left ventricular systolic dysfunction, and chronic heart failure
- (2008) Michael R. MacDonald et al. EUROPEAN HEART JOURNAL
- Activation of transcription factors and gene expression by oxidized low-density lipoprotein
- (2008) Cécile Mazière et al. FREE RADICAL BIOLOGY AND MEDICINE
- Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
- (2008) Tae-Sik Park et al. JOURNAL OF LIPID RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started